#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B precursor type acute leukaemia Neuromyelitis optica spectrum disorder Adenoid cystic carcinoma Osteosarcoma metastatic Bronchopulmonary dysplasia HER2 mutant non-small cell lung cancer Anti-myelin-associated glycoprotein associated polyneuropathy Philadelphia positive chronic myeloid leukaemia Anti-glomerular basement membrane disease Drug eruption Vascular malformation T-cell lymphoma Alport's syndrome Osteogenesis imperfecta Liver transplant rejection More trials…

    Learn about Rare Diseases

    Pemphigus – Basic Information Usher’s syndrome – Basic Information VEXAS syndrome Chondrosarcoma metastatic Pituitary-dependent Cushing’s syndrome – Trials in Disease Paraneoplastic neurological syndrome – Trials in Disease Pulmonary sarcoidosis – Treatment Carcinoid syndrome – Treatment Gaucher’s disease type III Mast cell activation syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ofatumumab M2Rlab Emtricitabine Spiramycin Ursodeoxycholic Acid Glasdegib Gs-5245 GSKVX000000030810 Acoramidis Hydrochloride Tucatinib Glyceryl Trinitrate Apitegromab Sacituzumab Govitecan Sibeprenlimab Sufentanil Pbf-999 Aluminium Hydroxide Thiocolchicoside ZIGAKIBART Nmd670 More therapies…

    Learn about Your Condition

    Synovial sarcoma metastatic Myocarditis post infection Mite allergy Relapsing multiple sclerosis Agitation Benign prostatic hyperplasia Foetal growth restriction Senile dementia Pulmonary congestion Small intestine adenocarcinoma Bone hypertrophy Leukoencephalopathy Pseudomyxoma peritonei Skin ulcer Viral myocarditis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Hyaluronidase (Human Recombinant)
    Czechia Denmark Germany Greece The Netherlands Poland +2

  • Study on Treatment-Free Intervals for Newly Diagnosed Multiple Myeloma Patients Using Daratumumab, Lenalidomide, and Dexamethasone

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Lenalidomide
    • Dexamethasone
    The Netherlands

  • Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Cocarboxylase Tetrahydrate
    • D-Biotin
    • Dexpanthenol
    Austria

  • Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Caffeine
    • Acetylsalicylic Acid
    Czechia Denmark France Germany Italy The Netherlands +3

  • Study on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Actinium (Ac 225) Oxodotreotide
    • Everolimus
    • L-Arginine Hydrochloride
    Belgium France The Netherlands Spain

  • Study Comparing Isotretinoin with Doxycycline, Tretinoin, and Adapalene for Moderate Acne in Patients with Skin of Color

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acne
    Investigated Drugs:
    • Adapalene
    • Isotretinoin
    • Lymecycline
    France
Previous Page
1 … 446 447 448 449 450 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!